Abstract:e22528 Background: The familiar history is indispensable to clinical investigation during genetic counseling and the new molecular techniques allowed the identification of hereditary cancer predisposition syndromes (CPS). However, the classification systems of these syndromes are difficulty and very complex. In 2015, the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) published guidelines for the assessment of variants in genes associated with Mendelian diseases to reduce the subjectivity bias of mutation variants classified as risk. Methods: To show the difficulty of classification of these variants we describe a case report of a family from countryside of Brazil in which there is a high rate of inbreeding. This family has three brothers with polyposis and colorectal cancer between 51 and 60 years-old. Results: The index-case had multiple polyps, developed colorectal cancer at 51 years-old and had a familiar history of two brother dead by colorectal cancer after polyposis and nine brother without familiar history of cancer, a father dead at 38 years-old by non-specific lung-disease and a mother alive at 83 years-old. There was no description of other cases of cancer among uncles and grandparents. The index-case performe a NSG genetic painel to CPS and showed a homozygosis variant in MUTYH gene: NM_001048174.1: c.253T > C:p.(Trp85Arg), that was classified as variant of uncertain significance (VUS). MUTYH is a base excision repair enzyme, it plays a crucial role in the correction of DNA errors and may be considered a cell protective factor and is associated with MUTYH-related polyposis (MAP). MAP is an autosomal recessive CPS and presents a phenotype that overlaps attenuated polyposis and familial adenomatous polyposis, increasing the risk of colorectal cancer in 43-63% up to 60 years or 80% if there is no surveillance/tracking. In view of the family history that suggests autosomal recessive inheritance, with a homozygous variant absent in the database of population controls (gnomAD) and in which in silico predictors indicate the effect of this variant as deleterious, the management of this family must be carried out considering it as a potential high-risk pathogenic variant. Conclusions: While the classification criteria for the variants are being refined, we reinforce the importance of a careful family history in the approach to CPS in order to offer an appropriate clinal conduct in the prevention of hereditary cancer.

Gorlin-Like Phenotype in a Young Girl With a De Novo PTCH2 Variant Mutation of Uncertain Significance

Germline PTCH1: c.361_362insAlu alteration identified by comprehensive exome and RNA sequencing in a patient with Gorlin syndrome

Further Expanding the Mutational Spectrum of Gorlin Syndrome in Three Unrelated Families

How drugs act-11. Drugs and sleep.

A new nonsense mutation of PTCH1 gene in mother and daughter with late-onset nevus basal cell carcinoma syndrome: Case report

PTCH Mutations in Sporadic and Gorlin-syndrome-related Odontogenic Keratocysts

PTCH Germline Mutations in Chinese Nevoid Basal Cell Carcinoma Syndrome Patients.

Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity

PTCH1 gene mutation and nevoid basal cell carcinoma syndrome:a case report

SUFU‐associated Gorlin syndrome: Expanding the spectrum between classic nevoid basal cell carcinoma syndrome and multiple hereditary infundibulocystic basal cell carcinoma

Bilateral Ovarian Fibromas As the Sole Manifestation of Gorlin Syndrome in a 22-Year-old Woman: a Case Report and Literature Review

Nevoid basal cell carcinoma syndrome

Limitations in surrogate measures of insulin resistance.

Gorlin-Goltz Syndrome - Clinical Case Report.

Development of mediastinal lymphoma after radiotherapy for concurrent medulloblastoma and PNET in a patient with Gorlin syndrome

Frequency of positive purified protein derivative test in those infected with human immunodeficiency virus.

Acquisition of drug resistance in basal cell nevus syndrome tumors through basal to squamous cell carcinoma transition

A Novel Mutation of the PTCH1 Gene Activates the Shh/Gli Signaling Pathway in a Chinese Family with Nevoid Basal Cell Carcinoma Syndrome.

MUTYH-related polyposis syndrome associated with a variant of uncertain significance mutation: A new pathogenic mutation?

Mutation analysis of the PTCH1 gene in a pedigree with nevoid basal cell carcinoma syndrome

A Long-Term Follow-Up of a Patient with a Novel PORCN Variant and Additional Clinical Features